George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 10,000 shares at $612.27 ($6.1M) on 2020-08-31, disclosed to the SEC on 2020-08-31.
Open-market sale of $6.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $610.45 | 3,600 | $2.2M | 35.9% |
| 2 | $611.38 | 1,400 | $856K | 14.0% |
| 3 | $612.27 | 2,000 | $1.2M | 20.0% |
| 4 | $613.54 | 1,100 | $675K | 11.0% |
| 5 | $614.51 | 1,900 | $1.2M | 19.1% |
| Total | $612.06 avg | 10,000 |
| $6.1M |
| 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |